Traumatic brain injury (TBI) causes substantial neurological disabilities and mental distress.
Annual TBI incidence is in magnitude of millions, making it a global health challenge …

Background The use of blood biomarkers after mild traumatic brain injury (mTBI) has been
widely studied. We have identified eight unresolved issues related to the use of five …

Mild traumatic brain injury (mTBI) accounts for approximately 80% of all TBI cases and is a
growing source of morbidity and mortality worldwide. To improve the management of …

Biomarkers such as calcium channel binding protein S100 subunit beta (S100B), glial
fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCH-L1) and neuron …

Introduction Traumatic brain injury (TBI) is a major global health issue, resulting in
debilitating consequences to families, communities, and health-care systems. Prior research …

Older adults have the highest incidence of traumatic brain injury globally. Accurate blood-
based biomarkers are needed to assist with diagnosis of patients across the spectrum of age …

Abstract The Scandinavian Guidelines for Initial Management of Minimal, Mild, and
Moderate Head Injuries in Adults (Scandinavian guidelines) are the first to incorporate …

Abstract Background In 2013 the Scandinavian Neurotrauma Committee (SNC) published
updated guidelines for the initial management of minimal, mild and moderate traumatic head …

The diagnosis and evaluation of traumatic brain injury (TBI) are crucial steps toward the
treatment and prognosis of patients. A common question remains as to whether it is possible …

Background Mild traumatic brain injury (mTBI) is one of the most common causes of
emergency department visits around the world. Up to 90% of injuries are classified as mTBI …